CytoDyn Inc. (CYDY) stock
CYDYOTCPharmaceutical PreparationsFiscal year ends May 31
$0.25+0.02 (+9.53%)
Close on Oct 19, 2026Market cap $345.56MP/E –Yield –
CytoDyn revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
CytoDyn's revenue for the twelve months ending May 31, 2022 was $266.00K. For fiscal 2023 it was $0, down 100.0% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | May 31, 2023 | $0 | -100.0% |
| FY2022 | May 31, 2022 | $266.00K | – |
| FY2021 | May 31, 2021 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022CQ2 2022 | May 31, 2022 | $0 | – |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | $0 | – |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | $225.00K | – |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | $41.00K | – |
| Q4 FY2021CQ2 2021 | May 31, 2021 | $0 | – |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | $0 | – |
| Q2 FY2021CQ4 2020 | Nov 30, 2020 | $0 | – |
| Q1 FY2021CQ3 2020 | Aug 31, 2020 | $0 | – |
See a number that looks wrong?